BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 32506921)

  • 1. Treatment Considerations for CNS Infections Caused by Vancomycin-Resistant
    Lee BJ; Vu BN; Seddon AN; Hodgson HA; Wang SK
    Ann Pharmacother; 2020 Dec; 54(12):1243-1251. PubMed ID: 32506921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraventricular daptomycin and intravenous linezolid for the treatment of external ventricular-drain-associated ventriculitis due to vancomycin-resistant Enterococcus faecium.
    Mueller SW; Kiser TH; Anderson TA; Neumann RT
    Ann Pharmacother; 2012 Dec; 46(12):e35. PubMed ID: 23232018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia.
    Britt NS; Potter EM; Patel N; Steed ME
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children.
    Tamma PD; Hsu AJ
    Curr Opin Infect Dis; 2014 Dec; 27(6):517-27. PubMed ID: 25313503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients.
    Britt NS; Potter EM; Patel N; Steed ME
    Clin Infect Dis; 2015 Sep; 61(6):871-8. PubMed ID: 26063715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of Patients With Vancomycin-Resistant Enterococcus faecium Bacteremia Treated With Conventional or High Doses of Daptomycin or Linezolid Is Associated With the Rate of Bacterial Clearance.
    Chuang YC; Lin HY; Chen PY; Lin CY; Chen YC; Wang JT; Chang SC
    Crit Care Med; 2018 Oct; 46(10):1634-1642. PubMed ID: 29957707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilizing genomic analyses to investigate the first outbreak of vanA vancomycin-resistant Enterococcus in Australia with emergence of daptomycin non-susceptibility.
    Douglas AP; Marshall C; Baines SL; Ritchie D; Szer J; Madigan V; Chan HT; Ballard SA; Howden BP; Buising K; Slavin MA
    J Med Microbiol; 2019 Mar; 68(3):303-308. PubMed ID: 30663951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of daptomycin non-susceptibility in colonizing vancomycin-resistant Enterococcus faecium isolates during daptomycin therapy.
    Lellek H; Franke GC; Ruckert C; Wolters M; Wolschke C; Christner M; Büttner H; Alawi M; Kröger N; Rohde H
    Int J Med Microbiol; 2015 Dec; 305(8):902-9. PubMed ID: 26454536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin-resistant enterococcal bacteremia pharmacotherapy.
    Patel R; Gallagher JC
    Ann Pharmacother; 2015 Jan; 49(1):69-85. PubMed ID: 25352037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged linezolid use is associated with the development of linezolid-resistant Enterococcus faecium.
    Smith TT; Tamma PD; Do TB; Dzintars KE; Zhao Y; Cosgrove SE; Avdic E
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):161-163. PubMed ID: 29496381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar efficacy and safety of daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bloodstream infections: a meta-analysis.
    Zhao M; Liang L; Ji L; Chen D; Zhang Y; Zhu Y; Patel K
    Int J Antimicrob Agents; 2016 Sep; 48(3):231-8. PubMed ID: 27475877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of risk factors and outcomes of daptomycin-susceptible and -nonsusceptible vancomycin-resistant Enterococcus faecium infections in liver transplant recipients.
    Lewis JD; Barros AJ; Sifri CD
    Transpl Infect Dis; 2018 Jun; 20(3):e12856. PubMed ID: 29427322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin-resistant Enterococcus faecium meningitis in adults: case series and review of the literature.
    Knoll BM; Hellmann M; Kotton CN
    Scand J Infect Dis; 2013 Feb; 45(2):131-9. PubMed ID: 22992165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Oritavancin Dosing Strategies against Vancomycin-Resistant Enterococcus faecium Isolates with or without Reduced Susceptibility to Daptomycin in an
    Belley A; Arhin FF; Moeck G
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of daptomycin or linezolid in combination with rifampin or gentamicin against biofilm-forming Enterococcus faecalis or E. faecium in an in vitro pharmacodynamic model using simulated endocardial vegetations and an in vivo survival assay using Galleria mellonella larvae.
    Luther MK; Arvanitis M; Mylonakis E; LaPlante KL
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4612-20. PubMed ID: 24867993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options for vancomycin-resistant enterococcal infections.
    Linden PK
    Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia.
    Kirkizlar TA; Akalin H; Kirkizlar O; Ozkalemkas F; Ozkocaman V; Kazak E; Ozakin C; Bulbul EN; Ozboz ES; Ali R
    Leuk Res; 2020 Dec; 99():106463. PubMed ID: 33130331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose.
    Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chang SC
    Clin Microbiol Infect; 2016 Oct; 22(10):890.e1-890.e7. PubMed ID: 27475738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of different antimicrobial therapies on clinical and fiscal outcomes of patients with bacteremia due to vancomycin-resistant enterococci.
    Hayakawa K; Martin ET; Gudur UM; Marchaim D; Dalle D; Alshabani K; Muppavarapu KS; Jaydev F; Bathina P; Sundaragiri PR; Rajuri SD; Khatri J; Pogue JM; Lephart PR; Rybak MJ; Kaye KS
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3968-75. PubMed ID: 24798267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tedizolid susceptibility in linezolid- and vancomycin-resistant Enterococcus faecium isolates.
    Klupp EM; Both A; Belmar Campos C; Büttner H; König C; Christopeit M; Christner M; Aepfelbacher M; Rohde H
    Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1957-1961. PubMed ID: 27525679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.